Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/07/070464
CTRI/2024/07/070464
Not yet recruiting
未知

Prevalence of metabolic syndrome and its risk factors in patients receiving Clozapine therapy for schizophrenia- A prospective observational study - NI

AIIMS Raipur0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: F209- Schizophrenia, unspecified

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F209- Schizophrenia, unspecified
Sponsor
AIIMS Raipur
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
AIIMS Raipur

Eligibility Criteria

Inclusion Criteria

  • •1\. All genders aged between 18 years to 65 years.
  • •2\. All patients with Schizophrenia diagnosed as per International Classification of disease 10 (ICD\-10\).
  • •3\. Patients prescribed Clozapine.
  • •4\. Medically stable patients.

Exclusion Criteria

  • •1\. Unstable patients i.e. patients with violence, suicide risk, and risk of harm to self/others.
  • •2\. Patients with diagnosable intellectual disability.
  • •3\. Pregnant or lactating patients.
  • •4\. Medically unstable patients.
  • •5\. Severely physical disability or locomotive disability.
  • •6\. History of substance dependence other than tea or coffee.
  • •7\. History of significant weight loss in the past month.
  • •8\. Patients on metabolism\-friendly medication (Such as Aripiprazole, Brexpiprazole, Lurasidone, Topiramate etc).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Metabolic syndrome in vitiligoHealth Condition 1: L80- Vitiligo
CTRI/2021/02/031393GSL Medical College and General Hospital
Completed
Not Applicable
Prevalence of the metabolic syndrome and its components in a Spanish community cohort: relation to lifestyle (estuDio de prEvalencia del síndrome meTabólico y sus componEntes: relaCión con el esTilo de vidA)
ISRCTN19527641Abbott Healthcare S.A. (Spain)10,000
Not yet recruiting
Not Applicable
Prevalence of metabolic syndrome(impaired glucose level, abnormal cholestrol level, abdominal obesity) and its determinants among fishermen community - Udupi.
CTRI/2017/07/009117J Swarna Lakshmi
Completed
Not Applicable
Effect of the modified Mediterranean diet for prevention of metabolic syndrome in patients undergoing liver transplantatioCondition 1: Metabolic Syndrome. Condition 2: Metabolic Syndrome. Condition 3: Metabolic Syndrome. Condition 4: Metabolic Syndrome. Condition 5: Metabolic Syndrome.Pure hyperglyceridaemiaEssential (primary) hypertensionElevated blood glucose levelAbnormal weight gainLipoprotein deficiency
IRCT2015012720841N1Vice-Chancellery of Research and Technology150
Recruiting
Not Applicable
Epidemiology and biology of the metabolic syndrome in adult survivors of childhood cancer.cardiovascular diseases100184241001331710003216
NL-OMON35166Erasmus MC, Universitair Medisch Centrum Rotterdam1,200